详情页 - 四川省肿瘤医院知识库

当前位置：首页 > 详情页

UBE2C: a potential therapeutic target and prognostic biomarker for prostate cancer patients

文献详情

资源类型：

Pubmed体系：

作者：

机构： [1]The First School of Clinical Medicine, Lanzhou University, Lanzhou City, Gansu Province 730000, China [2]Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou City, Gansu Province 730000, China [3]Medical Research and Translation Center, Chengdu Fifth People’s Hospital, Chengdu City, Sichuan Province 610000, China [4]Institute of Modern Physics, Chinese Academy of Sciences, Beijing 101408, China

出处：

DOI：

ISSN：

关键词： UBE2C Prostate cancer Cell cycle Molecular marker

摘要：

UBE2C (Ubiquitin-conjugating enzyme E2C) has been confirmed to be closely associated with the progression of various cancers, but its specific role and clinical diagnostic and prognostic value in prostate cancer (PRAD) remain unclear. This study systematically assessed the expression characteristics, prognostic significance, and genetic mutations of UBE2C in cancer patients by integrating data from databases such as TCGA, GEO, cBioPortal, and COSMIC. Experimentally, we explored the biological functions of UBE2C in the occurrence and development of PRAD using various methods, including functional enrichment analysis, CCK8 cell proliferation assay, colony formation assay, Transwell migration and invasion assay, Edu staining, 3D tumor spheroid culture, cell cycle analysis, apoptosis detection, and xenograft tumor models. After knocking down UBE2C expression, the proliferation ability, migration and invasion ability of PRAD cells, as well as the growth of xenograft tumors, were all inhibited, and the cell cycle process and apoptosis were changed accordingly. These findings provide favorable experimental evidence and theoretical support for UBE2C as a novel molecular marker for prognosis assessment in solid tumors.© 2025. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

语种：

PubmedID：

中科院(CAS)分区：

出版当年[2025]版：

大类 | 2 区生物学

小类 | 2 区遗传学

最新[2025]版：

大类 | 2 区生物学

小类 | 2 区遗传学

第一作者：

第一作者机构： [1]The First School of Clinical Medicine, Lanzhou University, Lanzhou City, Gansu Province 730000, China [2]Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou City, Gansu Province 730000, China

通讯作者：

通讯机构： [2]Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou City, Gansu Province 730000, China [4]Institute of Modern Physics, Chinese Academy of Sciences, Beijing 101408, China

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]DEPDC1 promotes cell proliferation and tumor growth via activation of E2F signaling in prostate cancer [2]Development of selective mono or dual PROTAC degrader probe of CDK isoforms. [3]Adapalene Inhibits Prostate Cancer Cell Proliferation In Vitro and In Vivo by Inducing DNA Damage, S-phase Cell Cycle Arrest, and Apoptosis. [4]LPCAT1 functions as a novel prognostic molecular marker in hepatocellular carcinoma (Open Access) [5]Cell cycle duration determines oncogenic transformation capacity [6]Downregulation of PDIA3 inhibits gastric cancer cell growth through cell cycle regulation [7]Molecular mechanisms underlying mangiferin-induced apoptosis and cell cycle arrest in A549 human lung carcinoma cells [8]RSPH14 regulates the proliferation, cell cycle progression, and apoptosis of non-small cell lung cancer cells [9]Cell cycle protein Bora serves as a novel poor prognostic factor in multiple adenocarcinomas [10]Defensins regulate cell cycle: Insights of defensins on cellular proliferation and division